These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 972983)

  • 1. Tryptamine in the brain and spinal cord: its role in the LSD response.
    Martin WR; Sloan JW; Vaupel DB
    Psychopharmacol Bull; 1976 Oct; 12(4):31-2. PubMed ID: 972983
    [No Abstract]   [Full Text] [Related]  

  • 2. The possible role of tryptamine in brain function and its relationship to the actions of LSD-like hallucinogens.
    Martin WR; Sloan JW
    Mt Sinai J Med; 1974; 41(2):276-82. PubMed ID: 4544624
    [No Abstract]   [Full Text] [Related]  

  • 3. Relationship of CNS tryptaminergic processes and the action of LSD-like hallucinogens.
    Martin WR; Sloan JW
    Pharmacol Biochem Behav; 1986 Feb; 24(2):393-9. PubMed ID: 3006088
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The action of tryptamine on the dog spinal cord and its relationship to the agonistic actions of LSD-like psychotogens.
    Martin WR; Eades CG
    Psychopharmacologia; 1970; 17(3):242-57. PubMed ID: 5310035
    [No Abstract]   [Full Text] [Related]  

  • 5. Cross tolerance to tryptamine in the LSD tolerant dog.
    Martin WR; Eades CG
    Psychopharmacologia; 1972; 27(2):93-8. PubMed ID: 4638212
    [No Abstract]   [Full Text] [Related]  

  • 6. Brain levels of tryptamine.
    Martin WR; Sloan JW; Christian ST; Clements TH
    Psychopharmacologia; 1972; 24(3):331-46. PubMed ID: 5034937
    [No Abstract]   [Full Text] [Related]  

  • 7. Dual actions of lysergic acid diethylamide tartrate (LSD), 2-bromo-D-lysergic acid diethylamide bitartrate (BOL) and methysergide on dorsal root potentials evoked by stimulation of raphe nuclei.
    Larson AA; Chinn C; Proudfit HK; Anderson EG
    J Pharmacol Exp Ther; 1981 Apr; 217(1):99-104. PubMed ID: 6110778
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modification of the effects of LSD-25, d-amphetamine and tryptamine on electrically evoked responses in the visual system by methiothepin and octoclothepin.
    Moore RH; Domino EF
    Arch Int Pharmacodyn Ther; 1978 Nov; 236(1):66-73. PubMed ID: 581833
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Studies of tryptamine and lysergic acid diethylamide (LSD) on cutaneous C-fiber and polysynaptic reflexes in the cat.
    Bell JA; Martin WR
    J Pharmacol Exp Ther; 1974 Sep; 190(3):492-500. PubMed ID: 4607113
    [No Abstract]   [Full Text] [Related]  

  • 10. [The effect of several psychotropic substances on brain structure].
    Popova EN; Krivitskaia GN
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1975; 75(7):1064-9. PubMed ID: 1210984
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The influence of LSD on the hind limb flexor reflex in the spinal rat.
    Palider W; Przewlocka B
    Pol J Pharmacol Pharm; 1975 Oct; 27(Suppl):173-9. PubMed ID: 1208225
    [No Abstract]   [Full Text] [Related]  

  • 12. Responses of the flexor reflex to LSD, tryptamine, 5-hydroxytryptophan, methoxamine, and d-amphetamine in acute and chronic spinal rats.
    Nozaki M; Bell JA; Vaupel DB; Martin WR
    Psychopharmacology (Berl); 1977 Nov; 55(1):13-8. PubMed ID: 414256
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Brain serotonin metabolism after tolerance dosage of LSD.
    Freedman DX; Boggan WO
    Adv Biochem Psychopharmacol; 1974; 10():151-7. PubMed ID: 4846536
    [No Abstract]   [Full Text] [Related]  

  • 14. Separation of tolerance to the behavioral effects of LSD from changes in serotonin receptor binding in cats.
    Trulson ME
    Eur J Pharmacol; 1985 May; 111(3):385-8. PubMed ID: 4018133
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Unsurmountable antagonism of brain 5-hydroxytryptamine2 receptors by (+)-lysergic acid diethylamide and bromo-lysergic acid diethylamide.
    Burris KD; Sanders-Bush E
    Mol Pharmacol; 1992 Nov; 42(5):826-30. PubMed ID: 1359397
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A new class of endogenous peptide factors.
    Vartanian GA; Varlinskaya EI
    Ann Ist Super Sanita; 1982; 18(1):53-5. PubMed ID: 7171174
    [No Abstract]   [Full Text] [Related]  

  • 17. A pharmacologic comparison of 3,4-methylenedioxyamphetamine and LSD in the chronic spinal dog.
    Nozaki M; Vaupel DB; Martin WR
    Eur J Pharmacol; 1977 Dec; 46(4):339-49. PubMed ID: 590343
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Suppression by LSD of the inhibiting effect of the dorsal nucleus of the raphe on the interneurons of layer V of the dorsal horn of the spinal cord in the cat].
    Guilbaud G; Besson JM; Oliveras JL; Liebeskind JC
    C R Acad Hebd Seances Acad Sci D; 1973 Jun; 276(25):3351-4. PubMed ID: 4199064
    [No Abstract]   [Full Text] [Related]  

  • 19. Factors influencing brain and tissue levels of tryptamine: species, drugs and lesions.
    Sloan JW; Martin WR; Clements TH; Buchwald WF; Bridges SR
    J Neurochem; 1975 Mar; 24(3):523-32. PubMed ID: 1113126
    [No Abstract]   [Full Text] [Related]  

  • 20. The effects of 5-hydroxytryptamine antagonists on spinal neuronal activity.
    Banna NR; Anderson EG
    J Pharmacol Exp Ther; 1968 Aug; 162(2):319-25. PubMed ID: 5302116
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.